Literature DB >> 34201964

Does Anatomical Contextual Information Improve 3D U-Net-Based Brain Tumor Segmentation?

Iulian Emil Tampu1,2, Neda Haj-Hosseini1,2, Anders Eklund1,2,3.   

Abstract

Effective, robust, and automatic tools for brain tumor segmentation are needed for the extraction of information useful in treatment planning. Recently, convolutional neural networks have shown remarkable performance in the identification of tumor regions in magnetic resonance (MR) images. Context-aware artificial intelligence is an emerging concept for the development of deep learning applications for computer-aided medical image analysis. A large portion of the current research is devoted to the development of new network architectures to improve segmentation accuracy by using context-aware mechanisms. In this work, it is investigated whether or not the addition of contextual information from the brain anatomy in the form of white matter (WM), gray matter (GM), and cerebrospinal fluid (CSF) masks and probability maps improves U-Net-based brain tumor segmentation. The BraTS2020 dataset was used to train and test two standard 3D U-Net (nnU-Net) models that, in addition to the conventional MR image modalities, used the anatomical contextual information as extra channels in the form of binary masks (CIM) or probability maps (CIP). For comparison, a baseline model (BLM) that only used the conventional MR image modalities was also trained. The impact of adding contextual information was investigated in terms of overall segmentation accuracy, model training time, domain generalization, and compensation for fewer MR modalities available for each subject. Median (mean) Dice scores of 90.2 (81.9), 90.2 (81.9), and 90.0 (82.1) were obtained on the official BraTS2020 validation dataset (125 subjects) for BLM, CIM, and CIP, respectively. Results show that there is no statistically significant difference when comparing Dice scores between the baseline model and the contextual information models (p > 0.05), even when comparing performances for high and low grade tumors independently. In a few low grade cases where improvement was seen, the number of false positives was reduced. Moreover, no improvements were found when considering model training time or domain generalization. Only in the case of compensation for fewer MR modalities available for each subject did the addition of anatomical contextual information significantly improve (p < 0.05) the segmentation of the whole tumor. In conclusion, there is no overall significant improvement in segmentation performance when using anatomical contextual information in the form of either binary WM, GM, and CSF masks or probability maps as extra channels.

Entities:  

Keywords:  3D U-Net; anatomical contextual information; artificial intelligence; automatic segmentation; high grade glioma; low grade glioma

Year:  2021        PMID: 34201964     DOI: 10.3390/diagnostics11071159

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  14 in total

1.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm.

Authors:  Y Zhang; M Brady; S Smith
Journal:  IEEE Trans Med Imaging       Date:  2001-01       Impact factor: 10.048

2.  Intraobserver and interobserver agreement in volumetric assessment of glioblastoma multiforme resection.

Authors:  Pieter L Kubben; Alida A Postma; Alfons G H Kessels; Jacobus J van Overbeeke; Henk van Santbrink
Journal:  Neurosurgery       Date:  2010-11       Impact factor: 4.654

Review 3.  Extent of Resection in Glioma-A Review of the Cutting Edge.

Authors:  Randy S D'Amico; Zachary K Englander; Peter Canoll; Jeffrey N Bruce
Journal:  World Neurosurg       Date:  2017-04-17       Impact factor: 2.104

Review 4.  FreeSurfer.

Authors:  Bruce Fischl
Journal:  Neuroimage       Date:  2012-01-10       Impact factor: 6.556

5.  Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features.

Authors:  Spyridon Bakas; Hamed Akbari; Aristeidis Sotiras; Michel Bilello; Martin Rozycki; Justin S Kirby; John B Freymann; Keyvan Farahani; Christos Davatzikos
Journal:  Sci Data       Date:  2017-09-05       Impact factor: 6.444

6.  DeepNAT: Deep convolutional neural network for segmenting neuroanatomy.

Authors:  Christian Wachinger; Martin Reuter; Tassilo Klein
Journal:  Neuroimage       Date:  2017-02-20       Impact factor: 6.556

7.  nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation.

Authors:  Fabian Isensee; Paul F Jaeger; Simon A A Kohl; Jens Petersen; Klaus H Maier-Hein
Journal:  Nat Methods       Date:  2020-12-07       Impact factor: 28.547

8.  Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups.

Authors:  Tareq A Juratli; Shilpa S Tummala; Julie J Miller; Daniel P Cahill; Angelika Riedl; Dirk Daubner; Silke Hennig; Tristan Penson; Amir Zolal; Christian Thiede; Gabriele Schackert; Dietmar Krex
Journal:  J Neurooncol       Date:  2018-12-07       Impact factor: 4.506

9.  Reproducibility and Bias in Healthy Brain Segmentation: Comparison of Two Popular Neuroimaging Platforms.

Authors:  Dana L Tudorascu; Helmet T Karim; Jacob M Maronge; Lea Alhilali; Saeed Fakhran; Howard J Aizenstein; John Muschelli; Ciprian M Crainiceanu
Journal:  Front Neurosci       Date:  2016-11-09       Impact factor: 4.677

10.  Re-epithelialization and immune cell behaviour in an ex vivo human skin model.

Authors:  Ana Rakita; Nenad Nikolić; Michael Mildner; Johannes Matiasek; Adelheid Elbe-Bürger
Journal:  Sci Rep       Date:  2020-01-08       Impact factor: 4.379

View more
  1 in total

1.  Automated detection and quantification of brain metastases on clinical MRI data using artificial neural networks.

Authors:  Irada Pflüger; Tassilo Wald; Fabian Isensee; Marianne Schell; Hagen Meredig; Kai Schlamp; Denise Bernhardt; Gianluca Brugnara; Claus Peter Heußel; Juergen Debus; Wolfgang Wick; Martin Bendszus; Klaus H Maier-Hein; Philipp Vollmuth
Journal:  Neurooncol Adv       Date:  2022-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.